Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center
In this real world, urban setting, for women undergoing laparotomy for gynecologic cancer, apixaban as post-operative VTE prophylaxis showed no increase in VTE events and appeared safe with no increase in bleeding events compared to LMWH. This study adds to the literature demonstrating that apixaban is safe and effective for VTE prophylaxis in our gynecologic oncology patients.
Authors
- Rebecca Mercier (ORCID: https://orcid.org/0000-0003-1584-1198)
- Norman D. Rosenblum (ORCID: https://orcid.org/0000-0003-1767-6464)
- Aaron Shafer (ORCID: https://orcid.org/0000-0003-2565-0264)
- Geno J. Merli (ORCID: https://orcid.org/0000-0002-8663-6872)
- Victoria Diamond
- Katherine Gerber
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Thomas Jefferson University Hospital (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1016/j.gore.2024.101535
- Citations
- 4
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.20